Word

METEOR

Status

Pending

Status Code

654

Status Date

Tuesday, April 16, 2024

Serial Number

79344258

Mark Type

4

Filing Date

Tuesday, November 9, 2021

Trademark Owner History

GammaDelta Therapeutics Ltd -
Adaptate Biotherapeutics Limited - Original Applicant

Classifications

5 Pharmaceuticals, namely, pharmaceutical preparations for the prevention and treatment of human disorders or diseases; antibodies and multi-specific antibodies, namely, colostral antibodies for medical purposes; biotechnological preparations for medical use; capsules sold empty for pharmaceuticals; drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drugs for medical purposes, namely, pharmaceutical products for the prevention and treatment of cancer; injectable pharmaceuticals, namely, pharmaceutical products for the prevention and treatment of cancer; medical preparations and articles, namely, pharmaceutical products for the prevention and treatment of cancer; medicines for human purposes, namely, pharmaceutical products for the prevention and treatment of cancer; pharmaceutical compositions namely, pharmaceutical products for the prevention and treatment of cancer; pharmaceutical drugs namely, pharmaceutical products for the prevention and treatment of cancer; pharmaceutical preparations namely, pharmaceutical products for the prevention and treatment of cancer; pharmaceutical preparations and substances namely, pharmaceutical products for the prevention and treatment of cancer; pharmaceutical preparations for activating cellular function; pharmaceutical preparations for human use namely, pharmaceutical products for the prevention and treatment of cancer; pharmaceutical preparations for immunity adjustment; pharmaceutical preparations for medical purposes namely, pharmaceutical products for the prevention and treatment of cancer; pharmaceutical preparations for regulating the immune system; pharmaceutical preparations for the prevention of autoimmune diseases; pharmaceutical preparations for the prevention of autoimmune disorders; pharmaceutical preparations for the treatment of autoimmune diseases; pharmaceutical preparations for the treatment of autoimmune disorders; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of viral diseases; pharmaceutical preparations for the treatment of anti-infective diseases; pharmaceutical preparations for the treatment of infectious diseases and for use in oncology; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of viral diseases; pharmaceutical preparations for the treatment of anti-infective diseases; pharmaceuticals preparations namely, pharmaceutical products for the prevention and treatment of cancer; biotechnological preparations for medical use in relation to antibodies and multi-specific antibodies for treating human diseases and disorders; biotechnological preparations for medical use in relation to gamma delta t cells; biotechnological preparations for medical use in relation to immunohistochemistry (IHC) and flow cytometry antibodies for treating human diseases and disorders; chemical preparations for pharmaceutical purposes in relation to antibodies and multi- specific antibodies for treating human diseases and disorders; chemical preparations for pharmaceutical purposes in relation to gamma delta t cells antibodies for treating human diseases and disorders; chemical preparations for pharmaceutical purposes in relation to immunohistochemistry (IHC) and flow cytometry antibodies for treating human diseases and disorders; chemicals for pharmaceutical use in relation to antibodies and multispecific antibodies for treating human diseases and disorders; chemicals for pharmaceutical use in relation to gamma delta t cells antibodies for treating human diseases and disorders; chemicals for pharmaceutical use in relation to immunohistochemistry (IHC) and flow cytometry antibodies for treating human diseases and disorders; drug delivery agents for controlled release of the active ingredients for a wide variety of pharmaceuticals in relation to antibodies and multi-specific antibodies; drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals in relation to gamma delta t cells; drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals in relation to immunohistochemistry (IHC) and flow cytometry; drugs for medical purposes in relation to antibodies and multi-specific antibodies for treating human diseases and disorders; drugs for medical purposes in relation to gamma delta t cells for treating human diseases and disorders; drugs for medical purposes in relation to immunohistochemistry (IHC) and flow cytometry for treating human diseases and disorders; pharmaceutical preparations in relation to antibodies and multi-specific antibodies for treating human diseases and disorders; pharmaceutical preparations in relation to gamma delta t cells for treating human diseases and disorders; pharmaceutical preparations in relation to immunohistochemistry (IHC) and flow cytometry for treating human diseases and disorders; pharmaceutical preparations in relation to antibodies and multi-specific antibodies for treating human diseases and disorders; pharmaceutical preparations in relation to gamma delta t cells for treating human diseases and disorders; pharmaceutical preparations in relation to immunohistochemistry (IHC) and flow cytometry for treating human diseases and disorders; pharmaceuticals in relation to antibodies and multispecific antibodies for treating human diseases and disorders; pharmaceuticals in relation to gamma delta t cells for treating human diseases and disorders; pharmaceuticals in relation to immunohistochemistry (IHC) and flow cytometry for treating human diseases and disorders; none of the aforesaid goods in relation to agriculture, horticulture or forestry

1 biological preparations for use in industry and science; biological substances, biological materials and biological preparations, and natural elements, namely proteins, peptide substrates, monoclonal antibodies, DNA, RNA, mRNA, cells and viruses for scientific, laboratory, medical and medical research use; biological preparations for use in science; monoclonal antibodies for scientific purposes, other than for medical or veterinary use; antibody reagents for scientific purposes; tagged monoclonal antibodies and multi-specific antibodies for scientific use; tagged monoclonal antibodies and multi-specific antibodies for laboratory use; proteins for binding antibodies and multi-specific antibodies for scientific, laboratory, medical and medical research use; proteins for detecting antibodies and multi-specific antibodies for scientific, laboratory, medical and medical research use; biochemical precursors for scientific purposes, namely, precursors for scientific, laboratory, medical and medical research use; biochemical preparations for scientific purposes, namely, precursors for scientific, laboratory, medical and medical research; biochemical reagents used for non-medical purposes; chemical substances, chemical materials and chemical preparations, and natural elements, namely proteins, peptides substrates, monoclonal antibodies, DNA, RNA, mRNA, cells and viruses in relation to antibodies and multi-specific antibodies for scientific, laboratory or medical research use; biological substances, biological materials and biological preparations, and natural elements, namely proteins, peptide substrates, monoclonal antibodies, DNA, RNA, mRNA, cells and viruses in relation to antibodies and multi-specific antibodies for scientific, laboratory, medical and medical research use; chemical substances, chemical materials and chemical preparations, and natural elements, namely proteins, peptide substrates, monoclonal antibodies, DNA, RNA, mRNA, cells and viruses in relation to immunohistochemistry (IHC) and flow cytometry for scientific, laboratory, medical and medical research use; biological substances, biological materials and biological preparations, and natural elements, namely proteins, peptide substrates, monoclonal antibodies, DNA, RNA, mRNA, cells and viruses in relation to immunohistochemistry (IHC) and flow cytometry for scientific, laboratory, medical and medical research use; chemical substances, chemical materials and chemical preparations, and natural elements, namely proteins, peptide substrates, monoclonal antibodies, DNA, RNA, mRNA, cells and viruses in relation to gamma delta t cells for scientific, laboratory, medical and medical research use; biological substances, biological materials and biological preparations, and natural elements, namely proteins, peptide substrates, monoclonal antibodies, DNA, RNA, mRNA, cells and viruses in relation to gamma delta t cells for scientific, laboratory, medical and medical research use; chemical substances, chemical materials and chemical preparations, and natural elements, namely proteins, peptide substrates, monoclonal antibodies, DNA, RNA, mRNA, cells and viruses in relation to immunohistochemistry (IHC) and flow cytometry for scientific, laboratory, medical and medical research use; biological substances, biological materials and biological preparations, and natural elements, namely proteins, peptides substrates, monoclonal antibodies, DNA, RNA, mRNA, cells and viruses in relation to immunohistochemistry (IHC) and flow cytometry for scientific, laboratory, medical and medical research use; chemical compositions and preparations for use in science in relation to antibodies and multispecific antibodies; chemical compositions and preparations for use in science in relation to gamma delta t cells; chemical compositions and preparations for use in science in relation to immunohistochemistry (IHC) and flow cytometry; chemical compositions and preparations for use in science in relation to immunohistochemistry (IHC) and flow cytometry; biological compositions and preparations for use in science in relation to antibodies and multi-specific antibodies; biological compositions and preparations for use in science in relation to gamma delta t cells; biological compositions and preparations for use in science in relation to immunohistochemistry (IHC) and flow cytometry; biological compositions and preparations for use in science in relation to immunohistochemistry (IHC) and flow cytometry; biochemical and biological precursors for scientific purposes in relation to antibodies and multi-specific antibodies; biochemical and biological precursors for scientific purposes in relation to gamma delta t cells; biochemical and biological precursors for scientific purposes in relation to immunohistochemistry (IHC) and flow cytometry; biochemical and biological precursors for scientific purposes in relation to immunohistochemistry (IHC) and flow cytometry; biochemical and biological preparations for scientific purposes in relation to antibodies and multi-specific antibodies; biochemical and biological preparations for scientific purposes in relation to gamma delta t cells; biochemical and biological preparations for scientific purposes in relation to immunohistochemistry (IHC) and flow cytometry; biochemical and biological preparations for scientific purposes in relation to immunohistochemistry (IHC) and flow cytometry; biochemical and biological reagents used for non-medical purposes in relation to antibodies and multi-specific antibodies; biochemical and biological reagents used for non-medical purposes in relation to gamma delta t cells; biochemical and biological reagents used for non-medical purposes in relation to immunohistochemistry (IHC) and flow cytometry; biochemical and biological reagents used for non-medical purposes in relation to immunohistochemistry (IHC) and flow cytometry; none of the aforesaid goods in relation to agriculture, horticulture or forestry or assays for research purposes

42 biological research; clinical research in the field of pharmaceuticals; medical research; biomedical research services; clinical trials, namely, scientific research in the nature of conducting clinical trials for others; conducting scientific clinical trials for pharmaceutical products for others; conducting early evaluations in the field of new pharmaceuticals; consultancy in the field of pharmaceutical research; consultancy relating to pharmaceutical research and development; development of pharmaceutical preparations and medicines; drug discovery services; information technology services for the pharmaceutical and healthcare industries; inspection of pharmaceuticals; laboratory research services relating to pharmaceuticals; medical and pharmacological research services; pharmaceutical drug development services; pharmaceutical product evaluation; pharmaceutical products development; pharmaceutical research and development; pharmaceutical research and development services; pharmaceutical research services; providing information about the results of clinical trials for pharmaceutical products; research and development in the pharmaceutical and biotechnology fields; research and development of vaccines and medicines; research and development services in the field of antibodies and multi-specific antibodies; research and development services in the field of antibody technology; scientific research relating to medicines; research and development in the field of medical diagnostic preparations; biological research, clinical research and medical research in relation to antibodies and multi-specific antibodies; biological research, clinical research and medical research in relation to gamma delta t cells; biological research, clinical research and medical research in relation to immunohistochemistry (IHC) and flow cytometry; consultancy relating to pharmaceutical research and development in relation to antibodies and multi-specific antibodies; consultancy relating to pharmaceutical research and development in relation to gamma delta t cells; consultancy relating to pharmaceutical research and development in relation to immunohistochemistry (IHC) and flow cytometry; laboratory research services relating to pharmaceuticals in relation to antibodies and multi-specific antibodies; laboratory research services relating to pharmaceuticals in relation to gamma delta t cells; laboratory research services relating to pharmaceuticals in relation to immunohistochemistry (IHC) and flow cytometry; medical and pharmacological research services in relation to antibodies and multi-specific antibodies; medical and pharmacological research services in relation to gamma delta t cells; medical and pharmacological research services in relation to immunohistochemistry (IHC) and flow cytometry; pharmaceutical research and development services in relation to antibodies and multi-specific antibodies; pharmaceutical research and development services in relation to gamma delta t cells; pharmaceutical research and development services in relation to immunohistochemistry (IHC) and flow cytometry; scientific and technological services in relation to scientific research in the field of antibodies and multi-specific antibodies; scientific and technological services in relation scientific research in the field of gamma delta t cells; scientific and technological services in relation scientific research in the field of immunohistochemistry (IHC) and flow cytometry; scientific research and development in relation to antibodies and multi-specific antibodies; scientific research and development in relation to gamma delta t cells; scientific research and development in relation to immunohistochemistry (IHC) and flow cytometry; information, advisory and consultancy services relating the aforesaid services, and none of the aforesaid services in relation to agriculture, horticulture or forestry

Trademark Events

Jul 7, 2022

Sn Assigned For Sect 66a Appl From Ib

Jul 8, 2022

New Application Office Supplied Data Entered

Jul 12, 2022

Application Filing Receipt Mailed

Aug 19, 2022

Assigned To Examiner

Aug 23, 2022

Non-Final Action Written

Aug 24, 2022

Non-Final Action (Ib Refusal) Prepared For Review

Sep 30, 2022

Refusal Processed By Mpu

Sep 30, 2022

Non-Final Action Mailed - Refusal Sent To Ib

Oct 26, 2022

Refusal Processed By Ib

Feb 4, 2023

Change Of Owner Received From Ib

Mar 29, 2023

Teas Response To Office Action Received

Mar 29, 2023

Correspondence Received In Law Office

Mar 30, 2023

Teas/Email Correspondence Entered

Apr 20, 2023

Suspension Letter Written

Apr 20, 2023

Letter Of Suspension E-Mailed

Apr 20, 2023

Notification Of Letter Of Suspension E-Mailed

Oct 18, 2023

Report Completed Suspension Check Case Still Suspended

Jan 2, 2024

Notification Of Possible Opposition - Processed By Ib

Dec 13, 2023

Notification Of Possible Opposition Sent To Ib

Dec 13, 2023

Notification Of Possible Opposition Created, To Be Sent To Ib

Apr 16, 2024

Report Completed Suspension Check Case Still Suspended

May 31, 2024

Change Of Name/Address Rec'd From Ib